PBH
Prestige Consumer Healthcare Inc.
-0.83 (-1.76%)46.04USD94.5K成交股數2.2B市值12.9本益比(近四季)2.0股價營收比+6.5%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 266M+6% | 282M-3% | 283M-0% | 274M+3% | 250M-10% | 290M+3% | 284M-1% | 267M-4% | 277M | 283M | 286M | 279M |
| 營業成本 | 130M | 135M | 126M | 123M | 109M | 129M | 126M | 121M | 125M | 125M | 126M | 125M |
| 毛利 | 136M-3% | 146M-9% | 157M-0% | 152M+4% | 140M-8% | 161M+2% | 157M-2% | 146M-6% | 152M | 158M | 160M | 155M |
| 毛利率 | 51.3% | 51.9% | 55.5% | 55.3% | 56.2% | 55.5% | 55.5% | 54.7% | 54.8% | 55.9% | 55.9% | 55.4% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 43.3M | 30.3M | 29.7M | 28.0M | 28.5M | 26.2M | 26.1M | 28.9M | 26.5M | 26.0M | 26.0M | 27.7M |
| 營業利益 | 52.5M-27% | 75.5M-18% | 82.5M-2% | 79.7M+11% | 71.8M-13% | 92.0M+6% | 84.3M-4% | 72.0M-15% | 82.2M | 86.8M | 88.3M | 85.2M |
| 營業利益率 | 19.8% | 26.8% | 29.1% | 29.1% | 28.8% | 31.7% | 29.7% | 27.0% | 29.7% | 30.7% | 30.8% | 30.5% |
| 稅後淨利 | 29.2M-39% | 53.9M-12% | 46.7M-14% | 42.2M-14% | 47.5M-4% | 61.0M+15% | 54.4M+2% | 49.1M-8% | 49.4M | 53.0M | 53.6M | 53.3M |
| 淨利率 | 11.0% | 19.1% | 16.5% | 15.4% | 19.0% | 21.0% | 19.2% | 18.4% | 17.8% | 18.8% | 18.7% | 19.1% |
| 稀釋 EPS | 0.61-36% | 1.13-7% | 0.97-11% | 0.86-12% | 0.95-3% | 1.22+15% | 1.09+2% | 0.98-8% | 0.98 | 1.06 | 1.07 | 1.06 |
| 稀釋股數 | 47.6M | 48.7M | 48.1M | 49.3M | 49.8M | 50.0M | 50.0M | 50.3M | 50.2M | 50.1M | 50.1M | 50.2M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 89.1M | 63.9M | 62.4M | 119M | 140M | 50.9M | 51.5M | 34.3M | 46.5M | 63.6M | 60.1M | 54.6M |
| 應收帳款 | 187M | 192M | 190M | 199M | 168M | 167M | 164M | 172M | 177M | 174M | 158M | 158M |
| 存貨 | 190M | 159M | 164M | 159M | 153M | 152M | 156M | 152M | 139M | 149M | 161M | 170M |
| 總資產 | 4.6B | 3.5B | 3.5B | 3.4B | 3.4B | 3.3B | 3.3B | 3.3B | 3.3B | 3.3B | 3.3B | 3.3B |
| 有息負債 | 2.0B | 994M | 1.0B | 993M | 993M | 1.0B | 1.1B | 1.1B | 1.1B | 1.2B | 1.3B | 1.3B |
| 總負債 | 2.7B | 1.6B | 1.7B | 1.6B | 1.6B | 1.5B | 1.6B | 1.6B | 1.7B | 1.7B | 1.8B | 1.9B |
| 股東權益 | 1.9B | 1.9B | 1.8B | 1.8B | 1.9B | 1.8B | 1.7B | 1.7B | 1.7B | 1.6B | 1.5B | 1.5B |
| 負債比 | 58.0% | 46.0% | 47.7% | 47.0% | 45.9% | 46.3% | 47.8% | 49.2% | 50.1% | 52.1% | 53.9% | 55.8% |
| 淨現金(現金 − 有息負債) | −1.9B | −930M | −971M | −874M | −853M | −949M | −1.0B | −1.1B | −1.1B | −1.1B | −1.2B | −1.3B |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 70.8M-10% | – | – | – | 79.0M | – | – | 54.8M+14% | – | – | – | 48.1M |
| 資本支出 | 3.7M | – | – | – | 838K | – | – | 1.2M | – | – | – | 1.5M |
| 自由現金流 | 67.1M-14% | – | – | – | 78.2M | – | – | 53.6M+15% | – | – | – | 46.6M |
| 折舊攤銷 | 8.8M | – | – | – | 7.7M | – | – | 8.1M | – | – | – | 7.5M |
| 買回庫藏股 | 0.00 | – | – | – | 34.8M | – | – | 26.0M | – | – | – | 25.0M |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | 25.2% | – | – | – | 31.3% | – | – | 20.1% | – | – | – | 16.7% |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 1.1B
| North American OTC Healthcare | 914M | 83.9% | -4.8% |
|---|---|---|---|
| International OTC Healthcare | 175M | 16.1% | -1.5% |
地區2026 年度 · 1.1B
| 美國 | 850M | 78.1% | -5.3% |
|---|---|---|---|
| 美國以外 | 238M | 21.9% | -0.8% |
產品／服務2026 年度 · 1.5B
| 產品 | 1.1B | 70.1% | -4.6% |
|---|---|---|---|
| Dermatologicals | 126M | 8.1% | -2.3% |
| Analgesics | 114M | 7.4% | -3.2% |
| Cough And Cold | 102M | 6.6% | -4.1% |
| Oral Care | 101M | 6.5% | +6.3% |
| Other Otc | 15.4M | 1.0% | +11.7% |
| Product And Service Other | 4.0M | 0.3% | +235.4% |
| Gastrointestinal 小計 | 260M | 16.8% | +1.5% |
| Womens Health 小計 | 228M | 14.7% | -3.8% |
| Eye And Ear Care 小計 | 143M | 9.2% | -22.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 1.1B | -4.3% | 190M | 17.5% | 3.91 | 246M |
| FY2025 | 1.1B | +1.1% | 215M | 18.9% | 4.29 | 243M |
| FY2024 | 1.1B | -0.2% | 209M | 18.6% | 4.17 | 239M |
| FY2023 | 1.1B | +3.8% | −82.3M | -7.3% | -1.65 | 222M |
| FY2022 | 1.1B | +15.2% | 205M | 18.9% | 4.04 | 250M |
| FY2021 | 943M | -2.0% | 165M | 17.5% | 3.25 | 213M |
| FY2020 | 963M | -1.3% | 142M | 14.8% | 2.78 | 203M |
| FY2019 | 976M | – | −35.8M | -3.7% | -0.69 | 179M |